Maine and Nevada Update Drug Price Transparency Laws
FDA Law Blog
JULY 22, 2021
Schlanger — Maine and Nevada previously enacted laws requiring drug manufacturers to report information about the pricing of their products. Finally, LD 686 updates the confidentiality provisions that apply to information disclosed to the state by manufacturers, wholesale drug distributors and PBMs. By Serra J.
Let's personalize your content